Header Logo

Connection

HASHEM EL-SERAG to Pharmacogenetics

Back to Details
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Pharmacogenetics.
HASHEM EL-SERAG
Connection Strength
0.022
Pharmacogenetics
  1. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials. 2012 May; 33(3):523-33.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.